Major depressive disorder (MDD) is a clinical condition that goes beyond ordinary sadness, affecting roughly 332 million people worldwide. It changes how you think, feel, sleep, eat, and engage with life, and it persists for weeks or months rather than passing in waves the way normal grief or disappointment does. About 5.7% of adults globally live with depression at any given time, with women affected at nearly twice the rate of men (6.9% versus 4.6%).
How It Differs From Normal Sadness
Everyone experiences sadness, loss, and low periods. The distinction between a rough stretch and MDD comes down to persistence, pervasiveness, and how deeply it disrupts daily functioning. In grief, painful feelings tend to come in waves and are often mixed with positive memories. In major depression, mood and thinking are almost constantly negative. Grief usually leaves your sense of self-worth intact. MDD tends to bring corrosive feelings of worthlessness and self-loathing that color everything.
Wanting to join a deceased loved one is a normal part of bereavement. Suicidal thoughts that exist independent of a specific loss, or feelings that the world would be better off without you, point toward depression as a clinical condition rather than a natural response to hardship.
Core Symptoms
MDD affects the body, mind, and behavior simultaneously. Emotionally, you may feel persistently sad, irritable, or strangely empty and apathetic. Physically, your body slows down. Fatigue becomes constant, sleep is disrupted (either too much or too little), and appetite shifts noticeably in one direction or the other. Concentration becomes difficult, decisions feel overwhelming, and motivation evaporates. Behaviorally, there’s a strong pull to withdraw from people, activities, and responsibilities you once cared about.
For a clinical diagnosis, at least five of these symptoms need to be present most of the day, nearly every day, for a minimum of two weeks. One of those five has to be either a persistently depressed mood or a loss of interest and pleasure in activities that previously felt rewarding.
Different Forms of Depression
Not everyone experiences MDD the same way. Clinicians recognize several subtypes that can look quite different from each other.
Melancholic depression is the form most people picture: a severe, heavy state with significant physical slowing, loss of appetite, disrupted sleep, and a pattern of feeling worst in the morning. People with this subtype tend to be unresponsive to things in their environment that would normally bring pleasure or relief. There is often prominent anxiety alongside the low mood.
Atypical depression, despite its name, is actually common. It looks different from the melancholic form in key ways. Mood can temporarily brighten in response to good news or enjoyable events. Sleep and appetite tend to increase rather than decrease. You might sleep 10 or 12 hours and still feel exhausted, or gain weight from increased eating. There’s often a heavy, leaden feeling in the arms and legs, and a long-standing sensitivity to interpersonal rejection.
What Happens in the Brain
Depression involves disruptions in how brain cells communicate with each other. Three chemical messengers play central roles. Serotonin helps regulate sleep, appetite, and mood, and also inhibits pain. People with depression often have reduced serotonin activity, and low levels of a serotonin byproduct have been linked to higher suicide risk. Norepinephrine influences motivation and reward, and may trigger anxiety when its signaling goes awry. Dopamine drives the brain’s reward system, affecting motivation and how you perceive reality.
The problem isn’t simply “low chemicals.” Receptors on brain cells may be oversensitive or insensitive, causing excessive or inadequate responses. The sending cell might release too little of a chemical messenger, or an overly efficient recycling process might clear the messenger away before it can do its job. It’s a communication breakdown more than a simple shortage.
Chronic depression also changes brain structure. A meta-analysis of brain imaging studies found that the hippocampus, a region critical for memory and emotional regulation, shrinks by 8 to 10% in people with depression. The more depressive episodes a person experiences, the greater the volume loss. This suggests that each untreated episode may leave a physical mark on the brain, making the case for early and sustained treatment.
Genetics and Environment
Twin studies consistently show that MDD is moderately heritable, with genetics accounting for roughly 30 to 50% of the risk. A large meta-analysis placed the estimate at 37%. Interestingly, the shared family environment (growing up in the same household) contributes very little, somewhere between 0 and 11%. The remaining risk comes from individual life experiences: trauma, chronic stress, relationship difficulties, loss, and other personal exposures that are unique to each person even within the same family.
What this means in practical terms is that having a parent or sibling with depression increases your risk but does not make it inevitable. Genes create vulnerability. Life circumstances, coping resources, and access to support determine whether that vulnerability becomes an active episode.
How Depression Is Treated
Therapy
Two forms of talk therapy have the strongest evidence for MDD. Cognitive behavioral therapy helps you identify and change the distorted thinking patterns that fuel depression: the automatic assumption that things will go wrong, that you’re not good enough, that nothing will improve. It’s a structured, skill-building approach that typically runs 12 to 20 sessions.
Interpersonal therapy takes a different angle. It focuses on improving your relationships and how you navigate social stressors like grief, conflict, major life transitions, and isolation. The premise is that you’re not to blame for your depression, but you are in a position to manage it by addressing the relationship patterns that trigger or worsen symptoms. Research on interpersonal therapy shows its strongest results in treating MDD specifically, and combining it with medication outperforms medication alone.
Medication
Antidepressants work by increasing the availability of serotonin, norepinephrine, or dopamine in the spaces between brain cells. The most commonly prescribed types, SSRIs and SNRIs, block the recycling process that pulls these chemical messengers back into the cell that released them, leaving more available to do their work. An older class, MAOIs, works differently by preventing an enzyme from breaking down these messengers. All of these approaches aim to restore more effective communication between brain cells.
Most people try one or two medications before finding the right fit. It typically takes four to six weeks to feel the full effect of a new antidepressant, and side effects often ease during that adjustment period.
Recurrence and Long-Term Outlook
One of the most important things to understand about MDD is its tendency to come back. In long-term studies, nearly two-thirds of people who recover from a first episode eventually experience at least one recurrence. The cumulative probability of a new episode reaches 25% within one year, 42% within two years, and 60% within five years.
Each recurrence makes the next one more likely and faster to arrive. After a first recurrence, the probability of a second jumps to 41% within one year and 74% within five years. The median time between episodes also shortens: about 150 weeks before the first recurrence, dropping to 83 weeks before the second, and continuing to compress with each subsequent episode.
This pattern is why many clinicians recommend staying on treatment well beyond the point where you feel better, particularly if you’ve already had two or more episodes. The goal shifts from just resolving the current episode to preventing the next one. Ongoing therapy, continued medication, or both can significantly extend the time between episodes and reduce their severity when they do occur.